XENIOS website relaunch

(PresseBox) ( Heilbronn, )
XENIOS AG, the leader in lung and heart assist therapies, unites the novalung, i-cor, and medos websites into www.xenios-ag.com to further advance the Xenios platform.

With the new XENIOS website, the Heilbronn-based medical device company further advances its unique lung and heart assist therapy platform. The corporate website now integrates the websites of the novalung, medos, and i-cor therapy brands.

As the leading provider of a lung and heart assist platform, the focus of the new online presence is on both - therapy and product. Customers and business partners will find tailored information at XENIOS CAMPUS, an online platform for clinical support, therapy information, and training. The integrated XENIOS Academy continues the tradition of the recognized novalung academy, and offers therapy-specific training options both on site at hospitals and in training centers.

Background information:

XENIOS AG is a leading therapy-driven medical device company focussed on lung and heart assist therapies. The novalung respiratory assist and the i-cor and medos cardiac assist therapies run on the unique Xenios platform.

This system addresses patients with isolated lung or heart failure. Our technologies set new standards in the field of pulmonary and cardiac support and support our patients’ mobility and active participation in the healing process.

Visit the new XENIOS AG “digital business card”:

www.xenios-ag.com
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.